IGC Pharma, Inc.
IGC· NYSE
IGC Pharma, Inc.
- Last sale
- Oct 6, 2026 · -1.05%
- Market cap
- $29.31M
- 103.38M shares
- Filings
- 815
Price
Oct 6, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-03-31 | $1,271,000 | reported | |
| FY 2024 | 2024-03-31 | $1,345,000 | reported | |
| FY 2023 | 2023-03-31 | $911,000 revised | reported | |
| FY 2022 | 2022-03-31 | $397,000 | reported | |
| FY 2021 | 2021-03-31 | $898,000 | reported | |
| FY 2020 | 2020-03-31 | $4,072,000 | reported | |
| FY 2019 | 2019-03-31 | $5,116,000 | reported | |
| FY 2018 | 2018-03-31 | $2,193,000 | reported | |
| FY 2017 | 2017-03-31 | $580,372 | reported | |
| FY 2016 | 2016-03-31 | $6,366,550 | reported | |
| FY 2015 | 2015-03-31 | $7,680,257 | reported | |
| FY 2014 | 2014-03-31 | $2,273,155 | reported |
IGC Pharma, Inc. · CIK 1326205 · Engraved from SEC EDGAR
